Safety and Efficacy of the Vascular Closure Device (Tonbridge) in Hemostasis Treatment of Femoral Artery Puncture

Inclusion Criteria: * Age 18-80, male or non-pregnant female; * Subjects undergoing unilateral femoral artery retrograde puncture for angiography or interventional procedure; * Using guide sheath ≥5F to ≤8F, and length ≤12cm in angiography or interventional procedure; * Subjects or their legal guardians voluntarily participate in this study, can complete follow-ups, and sign the informed consent form. Exclusion Criteria: * Ipsilateral common femoral artery occlusion or lumen diameter \< 5mm; * Inability to walk; * Allergy to contrast media; * Allergy to PGA or PEG; subjects with a history of common femoral artery surgery, percutaneous transluminal angioplasty (PTA), stent implantation, or vascular graft; * Subjects with bleeding tendency, such as thrombocytopenia (platelet count \<100×109/L), hemophilia, von willebrand diseases, pre-procedure INR \>1.5, etc.; * Subjects have taken anticoagulants for a long term before the procedure and have blood coagulation disorders; * BMI \>40kg/m\^2; * Subjects receive thrombolytic therapy (such as streptokinase, urokinase, t-PA) within≤24 hours before vascular closure; * Local infections or skin infections of the investigational limb; * Subjects with target femoral artery dissection or aneurysm within 30 days before intervention procedure; * Subjects with puncture site have been punctured through the posterior wall of the femoral artery, or have been punctured several times (≥3 times), or have bleeding or hematoma on the femoral arter…